Discontinuation report NAPROXEN-NA
| Report ID | 56681 |
| Drug Identification Number | 00887056 |
| Brand name | NAPROXEN-NA |
| Common or Proper name | NAPROXEN |
| Company Name | PRO DOC LIMITEE |
| Market Status | MARKETED |
| Active Ingredient(s) | NAPROXEN SODIUM |
| Strength(s) | 275MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | M01AE |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | |
| Remaining supply date | |
| Discontinuation status | Reversed |
| Discontinuation decision reversal | Yes |
| Information on remaining supply | |
| Company comments | This product has been re-introduced into the market. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
| Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2019-06-25 | French | Compare |
| v4 | 2019-06-25 | English | Compare |
| v3 | 2018-07-27 | English | Compare |
| v2 | 2018-07-26 | French | Compare |
| v1 | 2018-07-26 | English | Compare |
Showing 1 to 5 of 5